Tag: Multiple Myeloma
Risk for MGUS Up in WTC-Exposed Rescue/Recovery Workers
Risk for myeloma precursor disease, monoclonal gammopathy of undetermined significance, increased among WTC-exposed workers
Polypharmacy Prevalent Among Older Adults With Blood Cancers
Taking eight or more medications strongly associated with frailty; odds of being prefrail, frail increased with each additional med
Caregivers of Multiple Myeloma Patients Face Mental Health Issues
Among caregivers of multiple myeloma patients, 44.1 percent and 24.4 percent report anxiety and PTSD symptoms, respectively
A-Fib Linked to Worse Hospital Outcomes in Multiple Myeloma
In stratified analysis, odds of all-cause mortality, hospital stay of more than five days higher for MM patients not using anticoagulation
Frailty Mars Outcomes After aHSCT in Lymphoid Malignancies
Links found for frailty with in-hospital mortality, prolonged length of stay for patients with NHL, HL, MM undergoing aHSCT
Racial Disparities Persist in Multiple Myeloma Care, Outcomes
Hispanics have higher MM-related in-hospital mortality; recent decline seen in in-hospital mortality for all except NH-Blacks
Response to COVID-19 Vaccine Variable in Multiple Myeloma Patients
Considerable variation seen in magnitude of antibody response, from 5 to 7,882 AU/mL, following two doses of mRNA COVID-19 vaccine
Efficacy of BNT162b2 mRNA COVID-19 Vaccine Lower in Patients With CLL
Second study shows lower neutralizing antibody titers against SARS-CoV-2 after the first dose among elderly patients with multiple myeloma
Guidance Offered for Improving Diversity in Multiple Myeloma Trials
Ways to improve representation of African Americans in clinical trials could be extrapolated to other underrepresented groups
Renal Insufficiency May Worsen Multiple Myeloma Outcomes
Risk for disease progression or death increased for those with renal insufficiency in relapsed/refractory, newly diagnosed MM